About Dr. Ulrih Bitz
Dr. Ulrih Bitz (also spelled Dr. Ulrich Bitz) is the Chief Physician of the Oncology Department and Sarcoma Center at Helios Klinikum Berlin-Buch with over 11 years of experience as a Medical Oncologist. The Sarcoma Center he leads is part of the European Reference Network for Rare Tumors in Adults (EURACAN) — making him one of Europe's most recognised sarcoma specialists.
- 11+ years of experience as a Medical Oncologist
- Studied medicine at Ulm University, Germany (1999–2006)
- Worked as a doctor in Departments of Gastroenterology, Cardiology and Internal Medicine (2006–2009)
- Conducted clinical studies of new therapies in haematology and oncology from 2009
- Author of 3 scientific publications
Qualifications & Credentials
Medical Degrees
- Medical Studies — Ulm University, Germany (1999–2006)
Fellowships & Special Training
- Specialist training in Internal Medicine — Departments of Gastroenterology, Cardiology and Internal Medicine, Germany (2006–2009)
- Specialist training in Haematology and Oncology with focus on clinical trials of new therapies (from 2009)
- Specialised training in Soft Tissue and Bone Sarcoma management
- Specialised training in Modern Immunotherapy with Pembrolizumab (Keytruda)
Certifications & Accreditations
- German Medical Council (Berlin / Land Berlin) Registration
- German Society of Haematology and Oncology (DGHO) — Member
- European Society for Medical Oncology (ESMO) — Member
- European Reference Network for Rare Tumors in Adults (EURACAN) — Sarcoma Centre Member
Areas of Expertise
Major Conditions Treated
- Soft Tissue Sarcoma
- Leiomyosarcoma
- Osteosarcoma (Bone Sarcoma)
- Ewing's Sarcoma
- Rhabdomyosarcoma
- Chondrosarcoma
- Gastrointestinal Stromal Tumour (GIST)
- Liposarcoma
- Synovial Sarcoma
- Rare and Difficult-to-Treat Tumours
- Bone Metastases
- Solid Organ Cancers (general medical oncology)
- Haematological Malignancies (clinical trials)
Sub-specialties
- Sarcoma & Rare Tumour Oncology: Comprehensive medical oncology management of soft tissue sarcomas, bone sarcomas (osteosarcoma, Ewing's sarcoma, chondrosarcoma) and rare adult tumours — Helios Berlin-Buch Sarcoma Centre is part of the European Reference Network for Rare Tumors in Adults (EURACAN), the only Helios clinic in EURACAN.
- Modern Immunotherapy & Targeted Therapy: Comprehensive immunotherapy with Pembrolizumab (Keytruda), targeted therapy and personalised oncology — a leading Medical Oncologist specialist in Berlin, Germany for international patients.
- Clinical Trials in Haematology & Oncology: Active investigator in clinical trials of new therapies in haematology and oncology — relevant for international patients researching the best oncologist in Germany.
Advanced Procedures & Treatments
- Systemic Chemotherapy for Sarcomas
- Immunotherapy with Pembrolizumab (Keytruda)
- Targeted Therapy for Sarcomas and GIST
- Palliative and Supportive Cancer Care
- Multidisciplinary Sarcoma Tumour Board Coordination
- Clinical Trial Enrolment for Rare Tumours
- Personalised Oncology Treatment Planning
List of Disease and Treatment for which Dr. Ulrih Bitz can be consulted
Professional Experience
Current Affiliation
- Chief Physician (Chefarzt) — Oncology Department and Sarcoma Center, Helios Klinikum Berlin-Buch, Schwanebecker Chaussee 50, 13125 Berlin, Germany (Present)
Past Affiliations
- Departments of Gastroenterology, Cardiology and Internal Medicine, Germany — Resident Physician (2006–2009)
- Ulm University, Germany — Medical Student (1999–2006)
Academic & Research Roles
- Chief Physician — Sarcoma Center at Helios Klinikum Berlin-Buch (a EURACAN-affiliated centre)
- Active investigator in clinical studies of new therapies in haematology and oncology since 2009
- Author of 3 scientific publications
- Active member of multidisciplinary tumour board for rare tumours
Key Achievements
- 11+ years of experience as a Medical Oncologist
- Chief Physician of the Oncology Department and Sarcoma Center at Helios Klinikum Berlin-Buch
- Sarcoma Center is part of the European Reference Network for Rare Tumors in Adults (EURACAN) since 2020 — the only Helios clinic represented in EURACAN
- Author of 3 scientific publications
- Active investigator in clinical trials of new haematology and oncology therapies
Awards & Recognitions
National & International Awards
- Sarcoma Center at Helios Klinikum Berlin-Buch — European Reference Network for Rare Tumors in Adults (EURACAN) accreditation since 2020
Professional Memberships
- German Society of Haematology and Oncology (DGHO)
- European Society for Medical Oncology (ESMO)
- European Reference Network for Rare Tumors in Adults (EURACAN)
- German Medical Council (Land Berlin)
Research & Publications
Published Papers (Selected)
- Author of 3 scientific publications in haematology and medical oncology.
Ongoing Research & Clinical Interests
- Soft tissue sarcoma and bone sarcoma medical oncology
- Immunotherapy with Pembrolizumab (Keytruda)
- Targeted therapy in rare tumours
- Clinical trials of new therapies in haematology and oncology
- Multidisciplinary care for rare adult tumours (EURACAN)
Estimated Treatment Costs
| Procedure / Consultation | Estimated Cost (EUR) | Estimated Cost (USD) |
|---|---|---|
| Online / In-Person Consultation | €450 – €700 | $486 – $756 |
| Sarcoma Multidisciplinary Workup | €3,500 – €8,500 | $3,780 – $9,180 |
| Immunotherapy with Pembrolizumab (per cycle) | €6,500 – €9,500 | $7,020 – $10,260 |
| Systemic Chemotherapy for Sarcoma (per cycle) | €2,500 – €6,500 | $2,700 – $7,020 |
| Targeted Therapy (per month) | €4,500 – €9,000 | $4,860 – $9,720 |
| Sarcoma Treatment Package (Multidisciplinary) | €25,000 – €70,000 | $27,000 – $75,600 |
| Clinical Trial Evaluation | Variable (often subsidised) | Variable |
*Indicative estimates only. Actual costs subject to hospital pricing, case complexity, and insurance. Contact Cancer Rounds for a personalised quote.
Frequently Asked Questions
1. What advanced technologies does Dr. Ulrih Bitz use in Medical Oncologist treatment?
Dr. Ulrih Bitz uses advanced medical oncology technologies including modern immunotherapy with Pembrolizumab (Keytruda), targeted therapies for sarcomas and GIST, modern systemic chemotherapy protocols, EURACAN-aligned multidisciplinary sarcoma tumour boards, and clinical trial enrolment for new therapies in haematology and oncology. Virtual second opinions are also available for international patients.
2. What conditions does Dr. Ulrih Bitz specialize in treating?
Dr. Ulrih Bitz specialises in soft tissue sarcoma, leiomyosarcoma, osteosarcoma, Ewing's sarcoma, rhabdomyosarcoma, chondrosarcoma, GIST, liposarcoma, synovial sarcoma, rare and difficult-to-treat tumours, bone metastases, solid organ cancers, and haematological malignancies — making him a leading Sarcoma and Medical Oncologist specialist in Berlin, Germany.
3. How do I book an appointment with Dr. Ulrih Bitz?
Appointments with Dr. Ulrih Bitz can be booked directly through the Cancer Rounds website or by contacting their international patient department for priority scheduling.
4. Can international patients receive treatment from Dr. Ulrih Bitz?
Yes. Cancer Rounds provides full assistance for international patients seeking treatment from Dr. Ulrih Bitz, including medical visa invitation letters, airport transfers, and local accommodation coordination.
5. What support is available for international patients?
International patients benefit from a dedicated concierge service provided by Cancer Rounds, including language interpretation, financial counselling, and pre-travel virtual consultations to review medical records before arrival.
6. Does Dr. Ulrih Bitz offer second opinions for Medical Oncologist cases?
Yes. Second opinion consultations can be arranged via Cancer Rounds for patients who wish to review their diagnosis or treatment plan with an expert Medical Oncologist in Berlin, Germany — particularly relevant for soft tissue sarcoma, bone sarcoma, GIST, immunotherapy and clinical trial-eligible rare tumour cases at a EURACAN-accredited centre.
- Germany
